In July 2021, Yangtze River Pharmaceutical Group successfully ordered a 75 m³ cold storage for use in the freeze-drying workshop environment. It passed on-site acceptance.
Yangtze River Pharmaceutical Group adheres to innovation-driven high-quality development and implements the “three pharmaceuticals in parallel” innovation strategy of traditional Chinese medicine, chemical drugs and biologics. It has built 4 national-level R&D platforms, with more than 30 innovative drugs under development, forming a staged output pipeline of marketed products, products in R&D, and products in reserve. In 2021, its first Class 1 chemical innovative drug, Levornidazole Phosphate for Injection (disodium), was approved for marketing. As of October 25, 2022, a cumulative 124 generic drug varieties had passed or were deemed to have passed the quality and efficacy consistency evaluation. Five medicinal material quality standards drafted by the group were included in the European Pharmacopoeia; the group has also won 3 Second Prizes of the National Science and Technology Progress Award. The group persists in carrying forward the essence of traditional Chinese medicine and innovating on a sound foundation, promoting excellent traditional Chinese medicine culture. Based on the proven prescriptions of renowned veteran TCM practitioners and classical famous formulas, it has successfully developed more than 20 exclusive traditional Chinese medicines. Resonating with the “Healthy China” strategy, since 2014 it has fully built the “Longfengtang” traditional Chinese medicine industrial park, applying modern science and technology to transform traditional TCM production processes, pioneering intelligent manufacturing of traditional Chinese medicine. Longfengtang became a project unit of the Ministry of Industry and Information Technology's “New Model Application Project for Intelligent Factories in TCM Process Manufacturing” and the Standardization Administration of China's “National High-tech Industry Standardization Pilot for TCM Process Manufacturing”.